Copyright Reports & Markets. All rights reserved.

Global and Japan Multiplexed Diagnostics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Multiplexed Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Very High Density Multiplexed Assays (Above 10,000-plex)
    • 1.2.3 High Density Multiplexed Assays (500 Below plex Below 10,000)
    • 1.2.4 Medium Density Multiplexed Assays (plex Below 500)
    • 1.2.5 Low Density Multiplexed Assays (plex Below 5)
    • 1.2.6 Next Generation Sequencing Assays
  • 1.3 Market by Application
    • 1.3.1 Global Multiplexed Diagnostics Market Share by Application: 2020 VS 2026
    • 1.3.2 Academic Research Institutes
    • 1.3.3 Hospital
    • 1.3.4 Pharmaceutical Companies
    • 1.3.5 Clinical Research Organizations
    • 1.3.6 Diagnostic Laboratories
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Multiplexed Diagnostics Market Perspective (2015-2026)
  • 2.2 Global Multiplexed Diagnostics Growth Trends by Regions
    • 2.2.1 Multiplexed Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Multiplexed Diagnostics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Multiplexed Diagnostics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Multiplexed Diagnostics Players by Market Size
    • 3.1.1 Global Top Multiplexed Diagnostics Players by Revenue (2015-2020)
    • 3.1.2 Global Multiplexed Diagnostics Revenue Market Share by Players (2015-2020)
  • 3.2 Global Multiplexed Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Multiplexed Diagnostics Revenue
  • 3.4 Global Multiplexed Diagnostics Market Concentration Ratio
    • 3.4.1 Global Multiplexed Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Multiplexed Diagnostics Revenue in 2019
  • 3.5 Key Players Multiplexed Diagnostics Area Served
  • 3.6 Key Players Multiplexed Diagnostics Product Solution and Service
  • 3.7 Date of Enter into Multiplexed Diagnostics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Multiplexed Diagnostics Breakdown Data by Type (2015-2026)

  • 4.1 Global Multiplexed Diagnostics Historic Market Size by Type (2015-2020)
  • 4.2 Global Multiplexed Diagnostics Forecasted Market Size by Type (2021-2026)

5 Multiplexed Diagnostics Breakdown Data by Application (2015-2026)

  • 5.1 Global Multiplexed Diagnostics Historic Market Size by Application (2015-2020)
  • 5.2 Global Multiplexed Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Multiplexed Diagnostics Market Size (2015-2026)
  • 6.2 North America Multiplexed Diagnostics Market Size by Type (2015-2020)
  • 6.3 North America Multiplexed Diagnostics Market Size by Application (2015-2020)
  • 6.4 North America Multiplexed Diagnostics Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Multiplexed Diagnostics Market Size (2015-2026)
  • 7.2 Europe Multiplexed Diagnostics Market Size by Type (2015-2020)
  • 7.3 Europe Multiplexed Diagnostics Market Size by Application (2015-2020)
  • 7.4 Europe Multiplexed Diagnostics Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Multiplexed Diagnostics Market Size (2015-2026)
  • 8.2 China Multiplexed Diagnostics Market Size by Type (2015-2020)
  • 8.3 China Multiplexed Diagnostics Market Size by Application (2015-2020)
  • 8.4 China Multiplexed Diagnostics Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Multiplexed Diagnostics Market Size (2015-2026)
  • 9.2 Japan Multiplexed Diagnostics Market Size by Type (2015-2020)
  • 9.3 Japan Multiplexed Diagnostics Market Size by Application (2015-2020)
  • 9.4 Japan Multiplexed Diagnostics Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Multiplexed Diagnostics Market Size (2015-2026)
  • 10.2 Southeast Asia Multiplexed Diagnostics Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Multiplexed Diagnostics Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Multiplexed Diagnostics Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Agilent Technologies
    • 11.1.1 Agilent Technologies Company Details
    • 11.1.2 Agilent Technologies Business Overview
    • 11.1.3 Agilent Technologies Multiplexed Diagnostics Introduction
    • 11.1.4 Agilent Technologies Revenue in Multiplexed Diagnostics Business (2015-2020))
    • 11.1.5 Agilent Technologies Recent Development
  • 11.2 Bio-Rad Laboratories, Inc.
    • 11.2.1 Bio-Rad Laboratories, Inc. Company Details
    • 11.2.2 Bio-Rad Laboratories, Inc. Business Overview
    • 11.2.3 Bio-Rad Laboratories, Inc. Multiplexed Diagnostics Introduction
    • 11.2.4 Bio-Rad Laboratories, Inc. Revenue in Multiplexed Diagnostics Business (2015-2020)
    • 11.2.5 Bio-Rad Laboratories, Inc. Recent Development
  • 11.3 BioMerieux SA
    • 11.3.1 BioMerieux SA Company Details
    • 11.3.2 BioMerieux SA Business Overview
    • 11.3.3 BioMerieux SA Multiplexed Diagnostics Introduction
    • 11.3.4 BioMerieux SA Revenue in Multiplexed Diagnostics Business (2015-2020)
    • 11.3.5 BioMerieux SA Recent Development
  • 11.4 F. Hoffmann-La Roche Ltd.
    • 11.4.1 F. Hoffmann-La Roche Ltd. Company Details
    • 11.4.2 F. Hoffmann-La Roche Ltd. Business Overview
    • 11.4.3 F. Hoffmann-La Roche Ltd. Multiplexed Diagnostics Introduction
    • 11.4.4 F. Hoffmann-La Roche Ltd. Revenue in Multiplexed Diagnostics Business (2015-2020)
    • 11.4.5 F. Hoffmann-La Roche Ltd. Recent Development
  • 11.5 Illumina, Inc.
    • 11.5.1 Illumina, Inc. Company Details
    • 11.5.2 Illumina, Inc. Business Overview
    • 11.5.3 Illumina, Inc. Multiplexed Diagnostics Introduction
    • 11.5.4 Illumina, Inc. Revenue in Multiplexed Diagnostics Business (2015-2020)
    • 11.5.5 Illumina, Inc. Recent Development
  • 11.6 Luminex Corporation
    • 11.6.1 Luminex Corporation Company Details
    • 11.6.2 Luminex Corporation Business Overview
    • 11.6.3 Luminex Corporation Multiplexed Diagnostics Introduction
    • 11.6.4 Luminex Corporation Revenue in Multiplexed Diagnostics Business (2015-2020)
    • 11.6.5 Luminex Corporation Recent Development
  • 11.7 Hologic, Inc.
    • 11.7.1 Hologic, Inc. Company Details
    • 11.7.2 Hologic, Inc. Business Overview
    • 11.7.3 Hologic, Inc. Multiplexed Diagnostics Introduction
    • 11.7.4 Hologic, Inc. Revenue in Multiplexed Diagnostics Business (2015-2020)
    • 11.7.5 Hologic, Inc. Recent Development
  • 11.8 Thermo Fisher Scientific, Inc.
    • 11.8.1 Thermo Fisher Scientific, Inc. Company Details
    • 11.8.2 Thermo Fisher Scientific, Inc. Business Overview
    • 11.8.3 Thermo Fisher Scientific, Inc. Multiplexed Diagnostics Introduction
    • 11.8.4 Thermo Fisher Scientific, Inc. Revenue in Multiplexed Diagnostics Business (2015-2020)
    • 11.8.5 Thermo Fisher Scientific, Inc. Recent Development
  • 11.9 Siemens Healthineers
    • 11.9.1 Siemens Healthineers Company Details
    • 11.9.2 Siemens Healthineers Business Overview
    • 11.9.3 Siemens Healthineers Multiplexed Diagnostics Introduction
    • 11.9.4 Siemens Healthineers Revenue in Multiplexed Diagnostics Business (2015-2020)
    • 11.9.5 Siemens Healthineers Recent Development
  • 11.10 Abbott Laboratories
    • 11.10.1 Abbott Laboratories Company Details
    • 11.10.2 Abbott Laboratories Business Overview
    • 11.10.3 Abbott Laboratories Multiplexed Diagnostics Introduction
    • 11.10.4 Abbott Laboratories Revenue in Multiplexed Diagnostics Business (2015-2020)
    • 11.10.5 Abbott Laboratories Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Multiplexed Diagnostics Scope and Market Size
    Multiplexed Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Multiplexed Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Very High Density Multiplexed Assays (Above 10,000-plex)
    High Density Multiplexed Assays (500 Below plex Below 10,000)
    Medium Density Multiplexed Assays (plex Below 500)
    Low Density Multiplexed Assays (plex Below 5)
    Next Generation Sequencing Assays

    Market segment by Application, split into
    Academic Research Institutes
    Hospital
    Pharmaceutical Companies
    Clinical Research Organizations
    Diagnostic Laboratories

    Based on regional and country-level analysis, the Multiplexed Diagnostics market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Multiplexed Diagnostics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Agilent Technologies
    Bio-Rad Laboratories, Inc.
    BioMerieux SA
    F. Hoffmann-La Roche Ltd.
    Illumina, Inc.
    Luminex Corporation
    Hologic, Inc.
    Thermo Fisher Scientific, Inc.
    Siemens Healthineers
    Abbott Laboratories

    Buy now